What Beringea does

Beringea is a transatlantic venture capital firm founded in the 1980s that provides growth-stage capital to entrepreneurial companies in the UK, Europe, and the US Midwest. It operates two parallel fund structures: the ProVen VCT and ProVen Growth & Income VCT in the UK, which together manage more than £300m and target £1–10m investments in Series A or B rounds of UK and European companies with proven traction; and the Beringea US Funds (including the Michigan Growth Capital Partners family managed since 2008), which deploy $2–10m preferred equity in Midwest-based Series A or later-stage companies with ARR typically exceeding $3m. The firm has invested over £440m into more than 130 growth companies over 25 years and currently manages a global portfolio of 69 companies spanning healthcare, energy, fintech, proptech, supply chain, consumer, genomics, and defence technology.

Revenue is generated through management fees on institutional and private capital vehicles (including the ProVen VCTs with thousands of retail shareholders), the ProVen Estate Planning Service for business relief-qualifying investments, and carried interest from successful portfolio exits such as Micro-LAM ($90m+ sale to IDEX), WiredScore, AccessPay, Orbion Space Technology, and ATLAS Space Operations. Beringea LLP is FCA-regulated (FRN 496358) and Beringea, LLC is an SEC-registered investment adviser, giving the firm a dual regulatory footprint that few peers of comparable size match. Portfolio support is delivered through the Beringea Scale-Up Academy (virtual and in-person events covering B2B sales, coaching, and an "AI in Action" track) and biennial CEO retreats.

The go-to-market is relationship-driven, with deal sourcing reliant on a transatlantic network of entrepreneurs, operators, and advisers; UK capital is raised through VCT offer-for-subscription campaigns and institutional channels, while US capital is raised from institutional and accredited investors via the Michigan Growth Capital Partners structure. The firm is led by Founding Partners Charles Rothstein and Malcolm Moss, Managing Partners Michael Gross and Stuart Veale, and CIO Karen McCormick, supported by a partner bench that has expanded through internal promotions (e.g., Harry Thomas to Partner and Head of Portfolio in 2025).

Name

Beringea

Legal name

Beringea LLP

Website

https://beringea.com

Company type

Private

Founded year

1980

Operating status

Operating

Headcount range

11–50 employees

Short description

Beringea is a transatlantic venture capital firm managing £300m+ across ProVen VCTs and US growth funds, providing £1–10m (UK) and $2–10m (US) preferred-equity Series A/B investments to growth-stage entrepreneurs across healthcare, fintech, proptech, and consumer sectors.

Ownership category

akta.pro rank

Product category

Venture Capital / Private Equity

NAICS

Portfolio Management and Investment Advice (52394), Funds, Trusts, and Other Financial Vehicles (525)

SIC

Security Brokers, Dealers & Flotation Companies (6211)

akta.pro primary industry

Early-Stage Venture Capital (Series A/B) (FSANAAAB)

Keywords

• Venture capital
• Growth equity
• Venture capital trusts
• Private equity funds
• Portfolio company management

Headquarters

HQ city

Farmington Hills

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. VCT Fund Management: Manages ProVen VCT and ProVen Growth & Income VCT since their launches in 2000 and 2001. ProVen VCTs together manage more than £300m, investing in diversified portfolio of VCT-qualifying private companies.
2. US Fund Management: Beringea U.S. manages a family of funds targeting $2-10 million preferred equity investment opportunities in quickly scaling companies across a range of sectors.
3. Carried Interest: Returns from successful portfolio company exits drive carried interest. Notable exits include Micro-LAM ($90m+), AccessPay, WiredScore, ATLAS Space Operations, Orbion Space Technology.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

Beringea is a transatlantic venture capital firm that manages and deploys patient growth capital into rapidly scaling entrepreneurial companies. In the UK it manages the ProVen VCT and ProVen Growth & Income VCT (together over £300m, launched 2000 and 2001) and the ProVen Estate Planning Service. In the US it manages Beringea U.S. Funds, including the Michigan Growth Capital Partners family of funds, targeting $2–10M preferred equity investments in Midwest growth-stage companies. Typical investment sizes are £1–10m in the UK and $3–10m in the US, with the firm leading Series A or Series B rounds and providing follow-on capital.

Product overview

Beringea is a transatlantic venture capital firm offering a suite of investment fund products — the ProVen VCTs (managing over £300m across two UK-based Venture Capital Trusts launched in 2000 and 2001), the ProVen Estate Planning Service, and the Beringea U.S. Funds (targeting $2–10m preferred equity in growth-stage companies) — providing patient capital alongside portfolio support through the Beringea Scale-Up Academy. The portfolio includes companies with AI-driven products spanning healthcare analytics (Authenticx's conversational intelligence platform), remote surgery (Sovato Health's AI-powered platform), genomics (Genomenon's AI-driven analysis), supply chain optimization (Optilogic's Cosmic Frog solution), and customer experience (Chattermill's AI platform).

Differentiator

Problem solved

Functional benefit

Products and services

• ProVen Venture Capital Trusts (ProVen VCT and ProVen Growth & Income VCT) UK-based Venture Capital Trust funds managed by Beringea since launch. ProVen VCT and ProVen Growth & Income VCT together manage more than £300m, investing in a diversified portfolio of VCT-qualifying private companies identified by Beringea as having significant growth potential.
• ProVen Estate Planning Service (EPS) A flexible, discretionary portfolio service managed by Beringea that seeks to provide UK investors with a consistent level of return by investing in private trading companies expected to qualify for Business Relief.
• Beringea U.S. Funds (including Michigan Growth Capital Partners) A family of US funds managed by Beringea, LLC targeting $2–10 million preferred equity investment opportunities in quickly scaling companies across a range of sectors, with a geographic preference for the Midwest US. Funds focus on Series A, growth, or later-stage companies with proven business models, typically with ARR exceeding $3 million.

Quantifiable outcome

• AccessPay tripled its customer base during Beringea's investment period
• +4 more outcomes

Named customers12 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability10 records

Partnerships

One partnership is on record.

• General MotorspartnershipStrategic or Co-development Partner · 1 January 2025Optilogic partnered with General Motors to solve complex global supply chain decisions with real-time results monitoring.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Octopus Ventures: UK-based venture capital firm investing in similar Series A/B opportunities across the UK with comparable check sizes to Beringea's £1-10m UK range, competing directly for the same entrepreneur pool.
• Maven Capital Partners: UK regional investor managing VCTs and growth capital funds with similar structure to Beringea's ProVen VCT platform, competing for the same UK growth-stage companies.
• BGF (Business Growth Fund): UK growth investor providing equity capital to UK SMEs, directly competing with Beringea for mid-market growth deals and overlapping on Series A/expansion rounds in UK regions.
• Notion Capital: UK venture capital firm focused on Series A/B enterprise software and fintech with similar geography, stage, and check size to Beringea's UK technology growth investments.
• Albion Capital: UK VCT and growth capital manager operating multiple VCTs alongside enterprise and venture funds, structurally and competitively analogous to Beringea's ProVen-led UK franchise.
• Foresight Group: UK VCT and regional growth investor managing comparable fund vehicles (VCTs, regional funds) and competing for similar UK growth-stage opportunities with overlapping ticket sizes.
• MMC Ventures: UK venture capital firm investing in Series A in enterprise software, fintech, and consumer, with similar geography and stage focus to Beringea's UK Series A/B portfolio activity.
• Praetura Ventures: UK regional venture capital firm investing in growth-stage companies in Northern England, structurally comparable to Beringea's regional specialization but focused on the UK North rather than US Midwest.
• Draper Esprit: European venture capital firm (formerly EIS-focused) investing in Series A/B across UK and Europe with comparable check sizes and stage focus to Beringea's UK/European growth practice.

Regional players

• Plymouth Growth Partners: US Midwest (Ann Arbor, Michigan) growth equity firm investing in lower middle-market companies with revenue between $5m-$50m, comparable to Beringea U.S.'s Midwest Series A/expansion-stage mandate.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/Beringea
• LinkedInlinkedin.com/company/beringea-limited

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments194 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Beringea